Type of Herpes Virus Tied to Multiple Sclerosis
Type of Herpes Virus Tied to Multiple Sclerosis
A study of 16,000 people suggests that human herpesvirus 6A is a risk factor for developing multiple sclerosis, reinvigorating a neglected hypothesis that the virus could be involved in triggering the disease.
Type of Herpes Virus Tied to Multiple Sclerosis
Type of Herpes Virus Tied to Multiple Sclerosis

A study of 16,000 people suggests that human herpesvirus 6A is a risk factor for developing multiple sclerosis, reinvigorating a neglected hypothesis that the virus could be involved in triggering the disease.

A study of 16,000 people suggests that human herpesvirus 6A is a risk factor for developing multiple sclerosis, reinvigorating a neglected hypothesis that the virus could be involved in triggering the disease.

MS
MS Relief During Pregnancy Tied to Changes in T Cell Types
MS Relief During Pregnancy Tied to Changes in T Cell Types
Ashley P. Taylor | Nov 15, 2019
Many dominant T cell variants decline during pregnancy and reappear afterward, possibly explaining why relapses of the autoimmune disease are less common when women are expecting.
Northwestern University Stem Cell Therapy Clinic Closes Abruptly
Northwestern University Stem Cell Therapy Clinic Closes Abruptly
Katarina Zimmer | Sep 6, 2019
A Chicago-based center that has long operated a clinical trial program for stem cell therapies, has stopped recruiting further patients as its chief, Richard Burt, leaves for a research sabbatical.
Do Commensal Microbes Stoke the Fire of Autoimmunity?
Do Commensal Microbes Stoke the Fire of Autoimmunity?
Amanda B. Keener | Jun 1, 2019
Molecules produced by resident bacteria and their hosts may signal immune cells to attack the body’s own tissues.
Opinion: Predicting Perfect Storms
Opinion: Predicting Perfect Storms
Magali Haas | Oct 30, 2013
On embracing technology and collaboration to tackle brain disorders like multiple sclerosis
Drug Headlines of 2011
Hannah Waters | Dec 20, 2011
A list of this year’s newsworthy successes—and failures—in drug development